Today: 16 May 2026
Browse Category

Earnings Reports 5 January 2026 - 6 January 2026

Johnson & Johnson stock slips despite fresh bullish calls — what investors watch before earnings

Johnson & Johnson stock slips despite fresh bullish calls — what investors watch before earnings

Johnson & Johnson shares fell 1.47% to $204.31 Monday, underperforming the S&P 500’s 0.64% gain. UBS reiterated a Buy rating but lowered earnings forecasts after management warned of about $0.20 adjusted EPS dilution from the Halda Therapeutics acquisition. J&J will present at the JPMorgan Healthcare Conference Jan. 12 and report Q4 results Jan. 21.
6 January 2026
··
Costco stock climbs on Mizuho’s $1,000 call as December sales report nears

Costco stock climbs on Mizuho’s $1,000 call as December sales report nears

Costco shares rose 2.5% to $875.74 in after-hours trading Monday after Mizuho upgraded the stock and raised its price target to $1,000. The move comes ahead of Costco’s December sales report, due Jan. 7, which investors will watch for signs of steady traffic and membership growth. Mizuho cited strong demand and predicted high single-digit sales growth in coming quarters.
6 January 2026
··
UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth (UNH) stock gains after Barclays target hike as Jan. 27 earnings loom

UnitedHealth shares rose 1.7% to $342.02 Monday after Barclays raised its price target to $391 and reaffirmed an Overweight rating. The move came as investors positioned ahead of UnitedHealth’s Jan. 27 earnings and 2026 guidance. The stock traded between $333.86 and $346.83 on volume of 7.9 million shares. UnitedHealth remains well below its 52-week high of $606.36.
6 January 2026
··
Goldman Sachs stock jumps after Industry Ventures deal closes; Barclays lifts target ahead of earnings

Goldman Sachs stock jumps after Industry Ventures deal closes; Barclays lifts target ahead of earnings

Goldman Sachs shares climbed 3.8% after hours to $948.44 following news it closed its acquisition of Industry Ventures. Barclays raised its Goldman price target to $1,048 from $850, maintaining an Overweight rating. The S&P 500 financials index rose 2.2% Monday, with major banks hitting record highs. Goldman reports fourth-quarter results on Jan. 15.
6 January 2026
··
Palantir stock jumps nearly 4% after early-year swoon as traders eye jobs report, earnings

Palantir stock jumps nearly 4% after early-year swoon as traders eye jobs report, earnings

Palantir Technologies shares rose 3.7% to $174.04 Monday, recovering from a 5.6% drop Friday after a company officer filed to sell up to 12,000 shares. The stock traded between $166.35 and $181.35 during the session and was little changed after hours. Investors are watching Friday’s U.S. jobs report and Palantir’s next earnings, expected in early February.
5 January 2026
··
AMD stock slips after the bell ahead of Lisa Su’s CES keynote — what investors are watching

AMD stock slips after the bell ahead of Lisa Su’s CES keynote — what investors are watching

AMD shares fell 1.1% to $221.08 in after-hours trading Monday, ahead of CEO Lisa Su’s CES keynote at 9:30 p.m. ET. Nvidia slipped 0.4% while Intel was little changed. Investors are watching for concrete product timelines in AI PCs and data-center accelerators. AMD’s stock remains about 17% below its 52-week high, despite a 71% gain over the past year.
5 January 2026
···
Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum stock slides 8% as optics peers stumble; investors eye February earnings update

Lumentum Holdings shares dropped 7.6% to $356.69 Monday afternoon, leading declines among optical networking stocks as Coherent, Ciena, and Applied Optoelectronics also fell. The selloff followed a sharp rally that brought Lumentum near its December peak, with trading volume at 4.9 million shares by 3:24 p.m. EST. Investors are watching upcoming earnings and industry events for signs of continued AI-driven demand.
5 January 2026
·····
Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower (NXT) stock slides as solar shares wobble; $90 level and earnings in focus

Nextpower shares dropped 3.9% to $89.18 Monday, erasing an early surge and closing $3.60 below Friday’s finish. The move returned the stock to a key technical support zone after last year’s solar rally. Traders are watching for the company’s fiscal Q3 earnings, expected between Jan. 27 and Feb. 2. Broader solar stocks were mixed as investors awaited U.S. economic data for rate clues.
5 January 2026
······
Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific stock jumps as Evercore lifts target, with earnings in focus

Thermo Fisher Scientific shares climbed 2.4% to $606.63 after Evercore ISI raised its price target to $650 and reaffirmed an “outperform” rating. The stock traded between $590 and $608.29 on volume of 1.6 million shares. Peers Danaher, Agilent, and Illumina also advanced. Investors await Thermo Fisher’s fourth-quarter results on Jan. 29 and updates on its planned $9.4 billion Clario acquisition.
5 January 2026
···
Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus

Accenture stock rebounds nearly 2% as Redburn nudges target; dividend date and March earnings in focus

Accenture shares rose nearly 2% Monday to $265.07 after last week’s slide, following a price target increase by Rothschild & Co Redburn to $210. The company recently reported $20.9 billion in new bookings and declared a $1.63 quarterly dividend, payable Feb. 13. Accenture’s annual meeting is set for Jan. 28 in Dublin. Investors await its Q2 earnings call on March 19.
5 January 2026
···
JNJ stock slips as talc lawsuits return to the spotlight ahead of earnings

JNJ stock slips as talc lawsuits return to the spotlight ahead of earnings

Johnson & Johnson shares dropped 2.2% to $202.86 Monday, underperforming a rising market as investors rotated out of healthcare stocks. The move comes ahead of key events including the Jan. 9 U.S. jobs report and J&J’s Jan. 21 earnings call. More than 67,000 talc lawsuits remain unresolved, with a special master set to review expert evidence in New Jersey federal court.
5 January 2026
···
Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet stock slides nearly 7% today as contract manufacturers sell off; earnings in focus

Fabrinet shares dropped 6.7% to $447.36 by early afternoon Monday, defying gains in the S&P 500 and Nasdaq. The decline came ahead of the company’s quarterly update, with investors watching for signs of demand shifts after management set a high revenue target for the December quarter. Jabil, Celestica, and Flex also fell. The ISM manufacturing PMI slipped to 47.9 in December, signaling contraction.
5 January 2026
·····
1 … 157 158 159 160 161 … 248

Stock Market Today

  • Mosaic (MOS) Stock Drops 36%: Is It Undervalued Now?
    May 15, 2026, 10:18 PM EDT. Mosaic shares have fallen 36.3% over the past year amid concerns over fertilizers and crop demand. The stock dropped 13% year-to-date and 8.3% last month. Despite recent losses, a Discounted Cash Flow (DCF) analysis estimates Mosaic's intrinsic value at $39.74 per share-45.2% above the current price-indicating potential undervaluation. The DCF model relies on projected free cash flows improving from a recent $501.6 million outflow to $283.5 million in 2026 and $800 million by 2030. Mosaic holds a valuation score of 5 out of 6, signaling it trades below fair value estimates. Investors reconsider fertilizer sector risks amid volatile earnings, while some see opportunity in the materials sector.

Latest articles

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

16 May 2026
U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

16 May 2026
Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

16 May 2026
Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
Go toTop